Showing 2981-2990 of 9914 results for "".
Therapeutic Advances in the Topical Management of Acne
https://practicaldermatology.com/issues/supplements/therapeutic-advances-in-the-topical-management-of-acne/21618/Mechanism of Action Matters: A Review of New and Emerging Biologics
https://practicaldermatology.com/issues/supplements/mechanism-of-action-matters-a-review-of-new-and-emerging-biologics/23178/Erythema Multiforme Major Due to Fluconazole: A Case Report
https://practicaldermatology.com/youngmd-connect/resident-resource-center/erythema-multiforme-major-due-to-fluconazole-a-case-report/23887/Women in Dermatology: Iris Rubin, MD
https://practicaldermatology.com/topics/practice-management/women-in-dermatology-iris-rubin-md/23589/Women in Dermatology: Mona Gohara, MD
https://practicaldermatology.com/topics/practice-management/women-in-dermatology-mona-gohara-md/23556/Women in Dermatology: Melissa Kanchanapoomi Levin, MD
https://practicaldermatology.com/topics/practice-management/women-in-dermatology-melissa-kanchanapoomi-levin-md/23063/Prospective Analysis: PRP Post-Mohs; Physician Debt Insights
https://practicaldermatology.com/youngmd-connect/resident-resource-center/propsective-analysis-prp-post-mohs-physician-debt-insights/23038/New OTC Topicals Target Hyperpigmentation, Melasma
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/new-otc-topicals-target-hyperpigmentation-melasma/22081/There's a new and expanding menu of options to improve uneven tone, proving that OTCs can provide benefit for a vexing concern.A Novel Therapeutic Option for the Treatment of Molluscum Contagiosum
https://practicaldermatology.com/topics/general-topics/a-novel-therapeutic-option-for-the-treatment-of-molluscum-contagiosum/21040/There is no FDA approved treatment for molluscum. A novel intervention may erradicate Molluscum with one treatment.DermWireTV: Arcutis Takes PASI HD; Galderma at Camp Wonder; Amgen Challenge; LaRoche-Posay Pride
https://practicaldermatology.com/topics/psoriasis/dermwiretv-arcutis-takes-pasi-hd-galderma-at-camp-wonder-amgen-challenge-laroche-posay-pride/19996/The PASI high discrimination or PASI-HD tool was developed by Arcutis Biotherapeutics in collaboration with a panel of psoriasis research experts. Led by Amgen, in partnership with the International Federation of Psoriasis Associations, the Understanding Psoriatic Disease Leveraging Insights for Tre